3OKI PDB NFT

Crystal structure of human FXR in complex with (2S)-2-[2-(4-chlorophenyl)-1H-benzimidazol-1-yl]-N,2-dicyclohexylethanamide

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba

IPFS of NFT metadata:

bafybeicw5xv4mpzbtfs2oquxwjovlvnoifss5analbfqizttedeoodkaae/metadata.json

IPFS of structure file:

bafybeif2ctxh46fwluaob3mp2guis2vzzyefhg6bnjyekjoqi7vvfndk3m/3oki.pdb

MOLNFT PDB v1

NFT id:
74021
PDB ID:
3OKI
Name:
Crystal structure of human FXR in complex with (2S)-2-[2-(4-chlorophenyl)-1H-benzimidazol-1-yl]-N,2-dicyclohexylethanamide
Keywords:
HORMONE RECEPTOR
Experimental Method:
X-RAY DIFFRACTION
Resolution:
2.00

NFT data

MolNFT PDB v1 is The Protein Data Bank database (URL: https://rcsb.org) of protein structures minted as ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov, P.E. Bourne.
(2000) The Protein Data Bank Nucleic Acids Research, 28: 235-242.

MOLNFT 3OKI research and analysis (ICN3D with VR)

FASTA sequences

>3oki_A mol:protein length:233 Bile acid receptor
GSHMELTPDQQTLLHFIMDSYNKQRMPQEITNKILKEAFSAEENFLILTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSDLLEARIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPLLDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVNDHKFTPLLCEIWDVQ
>3oki_C mol:protein length:233 Bile acid receptor
GSHMELTPDQQTLLHFIMDSYNKQRMPQEITNKILKEAFSAEENFLILTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSDLLEARIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPLLDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVNDHKFTPLLCEIWDVQ
>3oki_B mol:protein length:14 peptide of Nuclear receptor coactivator 1
KDHQLLRYLLDKDE
>3oki_D mol:protein length:14 peptide of Nuclear receptor coactivator 1
KDHQLLRYLLDKDE

References and links

Current molecular structure file and data about current molecular structure file and NFT token based on it with
PDBID: 3OKI
TITLE: Crystal structure of human FXR in complex with (2S)-2-[2-(4-chlorophenyl)-1H-benzimidazol-1-yl]-N,2-dicyclohexylethanamide
DOI: 10.1016/j.bmcl.2010.11.039
AUTHORS: Rudolph, M.G.
ACCESSION DATE: 08/25/10
Obtained at RCSB PDB https://rcsb.org
RCSB Link: https://www.rcsb.org/structure/3OKI